Nan, X., Xie, C., Yu, X., & Liu, J. (2017). EGFR TKI as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer. Oncotarget.
Citação norma ChicagoNan, Xueli, Chao Xie, Xueyan Yu, and Jie Liu. "EGFR TKI As First-line Treatment for Patients With Advanced EGFR Mutation-positive Non-small-cell Lung Cancer." Oncotarget 2017.
MLA CitationNan, Xueli, Chao Xie, Xueyan Yu, and Jie Liu. "EGFR TKI As First-line Treatment for Patients With Advanced EGFR Mutation-positive Non-small-cell Lung Cancer." Oncotarget 2017.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.